# Quanex Building Products share price today (Quanex Building Products Corporation, NX)

> Quanex Building Products Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. NX · Industrials · Building Products & Equipment · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/nx

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $21.04 (+48.1% in a year)
- P/E: 21.1×, over 1 year
- Revenue (Jul 2026): $502 M (+1.3% on a year ago)
- Profit (Jul 2026): $26.5 M
- Operating margin: 9.3% (+2.7 points on a year ago)
- ROE: −35%, FY25
- ROIC: 4.5%, against a 6.7% cost of capital: −2.2 points

The main question: the share price moved +48.1% in a year while yearly earnings per share moved −703.6%. The difference came from the market paying a higher multiple. ## What is the Quanex Building Products share price today? Quanex Building Products Corporation's share price was $21.04 at the close on 3 November 2026. That is 10.0% above its average price over the last 200 trading days. In the last 52 weeks it traded between $12 and $23, and at that close it sat 83% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 1 week running. Over the last 1 year the share price moved +4% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Quanex Building Products pay? Quanex Building Products Corporation paid $0.32 per share over the last four reported quarters. The most recent declaration was $0.08 for Jul 2026. At today's price of $21.04 that is a yield of 1.52%, based on dividends already paid, not a forecast. ## Which stock lists is Quanex Building Products on? Quanex Building Products is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Quanex Building Products profitable? Quanex Building Products Corporation earned $26.5 M of net profit in the Jul 2026 quarter. The full FY25 year was a loss of $251 M. That is 5.3% of the quarter's revenue. The same quarter a year earlier lost $276 M. 4 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −$251 M (−858.7% on the year before). ## How much revenue does Quanex Building Products make, and is it growing? Quanex Building Products Corporation reported $502 M of revenue in the Jul 2026 quarter, +1.3% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 4 years it has grown 14.4% a year on average. The last full year, FY25, came in at $1.8 B. The last four reported quarters add to $1.9 B. FY25 revenue was $1.8 B, +43.8% on the year before. Recent pace: the last four quarters grew +1.3% on average, against 14.4% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +1.3%, against +31.3% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Quanex Building Products keep? Quanex Building Products Corporation's operating margin was 9.3% in the Jul 2026 quarter, 2.7 percentage points higher than the same quarter a year ago. Across 5 years it has been between 4.4% and 9.3%. The latest quarter is within that range. Why the margin moved: operating margin changed +2.7 percentage points on the year while gross margin changed +0.3 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Quanex Building Products' profit turning into cash? Over the last 3 years, 164% of Quanex Building Products Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $165 M of operating cash against −$251 M of profit. After $62.6 M of spending on assets, $102 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Quanex Building Products' cash go? Quanex Building Products Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $137 M on assets over the last 3 years. Averaged over those years that is 2.5% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $137 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Quanex Building Products' P/E ratio, and how does it compare with its own history? Quanex Building Products Corporation's P/E is 21.1×, with too little history to compare. Its usual P/E (the middle reading) is 22.7×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −703.6% while the price moved +48.1%. The price did better than earnings, which pushed the multiple up within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Quanex Building Products business getting better or worse? Quanex Building Products Corporation's business is getting worse. Profit and EPS growth are shrinking: profit growth is −1607.1% in the latest quarter, against +9.9% at its best in 12 quarters, with ROCE steady at 6.5%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Quanex Building Products earn on its capital? Quanex Building Products Corporation earned a ROE of −35% in FY25. Its return on capital used (ROIC) is 2.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −13.6% net margin and 0.93× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −13.6% net margin × 0.93× asset turnover × 2.71× leverage (assets divided by equity) ≈ −34.3% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 4.5% − 6.7% = −2.2 percentage points. The 6.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 4.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 7.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Quanex Building Products have too much debt? Quanex Building Products Corporation has total debt of $842 M against shareholder equity of $745 M as of Jul 2026, so its debt is 1.13× its equity. Year by year, that ratio went from 0.25 in FY21 to 1.18 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Quanex Building Products shareholding pattern? 7.3% of Quanex Building Products Corporation's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 6.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Quanex Building Products from balance-sheet trouble? For Quanex Building Products Corporation, the Z-score is 1.85. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.85 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Quanex Building Products rank in its industry? 54.1 out of 100, rank 9 of 29 in Building Products & Equipment, with 77% of the evidence available. Quanex Building Products Corporation scores 54.1 out of 100 against the 29 companies it is compared with in Building Products & Equipment, ranking 9. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.8 + 7.6 + 10.9 + 14.8 = 54.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Quanex Building Products compared with? Quanex Building Products ranks 9 of 29 Building Products & Equipment companies on the 4-Factor Sector Score, with 54.1 out of 100. 1. [Masco Corporation](https://www.sectoralpha.in/us/stocks/mas) MAS · turning · Most evidence points up · 81% evidence 72.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue -0.6% · Profit 9.8% · Operating margin change 3.5 points · 83% evidence Capital efficiency 21.4/25 · ROCE 36.1% · Operating margin 23.6% · 76% evidence Valuation 11.9/20 · P/E 18.6× · PEG 1.25 · 65% evidence Relative strength 18.6/20 · Lead over its industry 20.8% · Lead over S&P 500 12% · 1 year 32.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 20.3 + 21.4 + 11.9 + 18.6 = 72.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Johnson Controls International plc](https://www.sectoralpha.in/us/stocks/jci) JCI · losing its lead · Most evidence points up · 81% evidence 67.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 6.8% · Profit 60.7% · Operating margin change 2.2 points · 83% evidence Capital efficiency 13.7/25 · ROCE 13.2% · Operating margin 15.9% · 76% evidence Valuation 14.2/20 · P/E 24.9× · PEG 0.47 · 65% evidence Relative strength 14.3/20 · Lead over its industry 12.7% · Lead over S&P 500 4.8% · 1 year 22.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 25.1 + 13.7 + 14.2 + 14.3 = 67.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Apogee Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/apog) APOG · turning · Most evidence points up · 85% evidence 66.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.2/35 · Revenue 3% · Profit 54.5% · Operating margin change 0.1 points · 95% evidence Capital efficiency 11.1/25 · ROCE 11.9% · Operating margin 8.8% · 76% evidence Valuation 15.7/20 · P/E 12.5× · PEG 0.23 · 65% evidence Relative strength 19.5/20 · Lead over its industry 22.4% · Lead over S&P 500 13.4% · 1 year 33.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 20.2 + 11.1 + 15.7 + 19.5 = 66.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Griffon Corporation](https://www.sectoralpha.in/us/stocks/gff) GFF · quiet · Most evidence points up · 74% evidence 65.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 2% · Profit 100% · Operating margin change -1.4 points · 62% evidence Capital efficiency 19.2/25 · ROCE 27.3% · Operating margin 23.6% · 76% evidence Valuation 13.9/20 · P/E 25× · PEG 0.53 · 65% evidence Relative strength 15.2/20 · Lead over its industry 20.7% · Lead over S&P 500 12.1% · 1 year 41.6% · 100% evidence · 4 of 12 weeks ahead Exact sum: 17.6 + 19.2 + 13.9 + 15.2 = 65.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Carlisle Companies Incorporated](https://www.sectoralpha.in/us/stocks/csl) CSL · turning · Evidence leans up · 81% evidence 64.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Revenue 1.9% · Profit -10.2% · Operating margin change -0.5 points · 83% evidence Capital efficiency 19.0/25 · ROCE 19.1% · Operating margin 22.8% · 76% evidence Valuation 15.4/20 · P/E 20.3× · PEG 0.21 · 65% evidence Relative strength 16.7/20 · Lead over its industry 14.2% · Lead over S&P 500 5.6% · 1 year 21.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 13.2 + 19 + 15.4 + 16.7 = 64.3 · What this means: Relative strength against the index is 5.6%, and revenue and profit growth are weak. 6. [Perma-Pipe International Holdings, Inc.](https://www.sectoralpha.in/us/stocks/ppih) PPIH · breaking out · Evidence leans up · 85% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.7/35 · Revenue 24.2% · Profit 42.9% · Operating margin change -3.7 points · 95% evidence Capital efficiency 12.7/25 · ROCE 15.5% · Operating margin 7.1% · 76% evidence Valuation 15.4/20 · P/E 12.6× · PEG 0.24 · 65% evidence Relative strength 13.4/20 · Lead over its industry 2.4% · Lead over S&P 500 -5.1% · 1 year 5.7% · 100% evidence · 8 of 12 weeks ahead Exact sum: 18.7 + 12.7 + 15.4 + 13.4 = 60.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Trex Company, Inc.](https://www.sectoralpha.in/us/stocks/trex) TREX · turning · Evidence leans up · 81% evidence 58.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.4/35 · Revenue 6.8% · Profit -11.1% · Operating margin change -5.8 points · 83% evidence Capital efficiency 19.6/25 · ROCE 20.7% · Operating margin 20.6% · 76% evidence Valuation 7.8/20 · P/E 29.3× · PEG 1.96 · 65% evidence Relative strength 19.6/20 · Lead over its industry 22.9% · Lead over S&P 500 14% · 1 year 51.7% · 100% evidence · 5 of 12 weeks ahead Exact sum: 11.4 + 19.6 + 7.8 + 19.6 = 58.4 · What this means: Relative strength against the index is 14%, and revenue and profit growth are weak. 8. [Armstrong World Industries, Inc.](https://www.sectoralpha.in/us/stocks/awi) AWI · quiet · Evidence leans up · 81% evidence 55.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 8.4% · Profit 6.8% · Operating margin change 0 points · 83% evidence Capital efficiency 18.6/25 · ROCE 19% · Operating margin 21.6% · 76% evidence Valuation 6.7/20 · P/E 21.7× · PEG 2.66 · 65% evidence Relative strength 11.0/20 · Lead over its industry 1.4% · Lead over S&P 500 -6.3% · 1 year -9.3% · 100% evidence · 4 of 12 weeks ahead Exact sum: 19.4 + 18.6 + 6.7 + 11 = 55.7 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 9. Quanex Building Products Corporation this page NX · quiet · Evidence leans up · 77% evidence 54.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 1.3% · Profit n/a · Operating margin change 2.7 points · 71% evidence Capital efficiency 7.6/25 · ROCE 6.5% · Operating margin 9.3% · 76% evidence Valuation 10.9/20 · P/E 17.9× · PEG 1.53 · 65% evidence Relative strength 14.8/20 · Lead over its industry 18% · Lead over S&P 500 9.4% · 1 year 61.1% · 100% evidence · 6 of 12 weeks ahead Exact sum: 20.8 + 7.6 + 10.9 + 14.8 = 54.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Latham Group, Inc.](https://www.sectoralpha.in/us/stocks/swim) SWIM · turning · Evidence leans up · 64% evidence 52.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Revenue 10.6% · Profit n/a · Operating margin change -0.2 points · 62% evidence Capital efficiency 6.5/25 · ROCE 4.7% · Operating margin 14.1% · 76% evidence Valuation 8.5/20 · P/E 141.3× · PEG n/a · 15% evidence Relative strength 17.9/20 · Lead over its industry 19.9% · Lead over S&P 500 11.1% · 1 year 7.2% · 100% evidence · 6 of 12 weeks ahead Exact sum: 19.6 + 6.5 + 8.5 + 17.9 = 52.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Advanced Drainage Systems, Inc.](https://www.sectoralpha.in/us/stocks/wms) WMS · basing · Evidence leans up · 81% evidence 51.5 out of 100 Growth Capital Valuation Relative
12. [AAON, Inc.](https://www.sectoralpha.in/us/stocks/aaon) AAON · basing · Evidence leans up · 81% evidence 50.2 out of 100 Growth Capital Valuation Relative
13. [SPX Technologies, Inc.](https://www.sectoralpha.in/us/stocks/spxc) SPXC · basing · Evidence leans down · 81% evidence 49.8 out of 100 Growth Capital Valuation Relative
14. [Arlo Technologies, Inc.](https://www.sectoralpha.in/us/stocks/arlo) ARLO · basing · Evidence leans down · 64% evidence 47.0 out of 100 Growth Capital Valuation Relative
15. [Owens Corning](https://www.sectoralpha.in/us/stocks/oc) OC · quiet · Too little evidence to rank firmly · 56% evidence 46.7 out of 100 Growth Capital Valuation Relative
16. [Trane Technologies plc](https://www.sectoralpha.in/us/stocks/tt) TT · quiet · Evidence leans down · 81% evidence 46.4 out of 100 Growth Capital Valuation Relative
17. [Limbach Holdings, Inc.](https://www.sectoralpha.in/us/stocks/lmb) LMB · turning · Evidence leans down · 81% evidence 45.8 out of 100 Growth Capital Valuation Relative
18. [NPK International Inc.](https://www.sectoralpha.in/us/stocks/npki) NPKI · quiet · Evidence leans down · 64% evidence 45.8 out of 100 Growth Capital Valuation Relative
19. [Fortune Brands Innovations, Inc.](https://www.sectoralpha.in/us/stocks/fbin) FBIN · basing · Evidence leans down · 81% evidence 45.6 out of 100 Growth Capital Valuation Relative
20. [Lennox International Inc.](https://www.sectoralpha.in/us/stocks/lii) LII · basing · Evidence leans down · 81% evidence 45.3 out of 100 Growth Capital Valuation Relative
21. [Janus International Group, Inc.](https://www.sectoralpha.in/us/stocks/jbi) JBI · basing · Too little evidence to rank firmly · 58% evidence 40.9 out of 100 Growth Capital Valuation Relative
22. [Carrier Global Corporation](https://www.sectoralpha.in/us/stocks/carr) CARR · basing · Evidence leans down · 81% evidence 38.8 out of 100 Growth Capital Valuation Relative
23. [Gibraltar Industries, Inc.](https://www.sectoralpha.in/us/stocks/rock) ROCK · basing · Evidence leans down · 71% evidence 38.3 out of 100 Growth Capital Valuation Relative
24. [Louisiana-Pacific Corporation](https://www.sectoralpha.in/us/stocks/lpx) LPX · basing · Evidence leans down · 81% evidence 35.9 out of 100 Growth Capital Valuation Relative
25. [Builders FirstSource, Inc.](https://www.sectoralpha.in/us/stocks/bldr) BLDR · basing · Most evidence points down · 81% evidence 34.3 out of 100 Growth Capital Valuation Relative
26. [Aspen Aerogels, Inc.](https://www.sectoralpha.in/us/stocks/aspn) ASPN · losing its lead · Most evidence points down · 64% evidence 31.3 out of 100 Growth Capital Valuation Relative
27. AirJoule Technologies Corporation AIRJ · quiet · Too little evidence to rank firmly · 58% evidence 27.8 out of 100 Growth Capital Valuation Relative
28. [Madison Air Solutions Corporation](https://www.sectoralpha.in/us/stocks/mair) MAIR · quiet · Too little evidence to rank firmly · 31% evidence 52.9 out of 100 Growth Capital Valuation Relative
29. JELD-WEN Holding, Inc. JELD · Too little evidence to rank firmly · 44% evidence 32.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Building Products & Equipment](https://www.sectoralpha.in/us/sectors/building-products-equipment), all 29 compared on one page. ## Which companies are close to Quanex Building Products in size? Quanex Building Products is the 21st largest of 27 Building Products & Equipment companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Arlo Technologies, Inc., Gibraltar Industries, Inc. and Apogee Enterprises, Inc. Just below it: Latham Group, Inc., NPK International Inc. and Janus International Group, Inc. ### Building Products & Equipment companies close in size

1. [Arlo Technologies, Inc.](https://www.sectoralpha.in/us/stocks/arlo) $1.5 billion
2. [Gibraltar Industries, Inc.](https://www.sectoralpha.in/us/stocks/rock) $1.2 billion
3. [Apogee Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/apog) $958 million
4. Quanex Building Products Corporation $955 million
5. [Latham Group, Inc.](https://www.sectoralpha.in/us/stocks/swim) $861 million
6. [NPK International Inc.](https://www.sectoralpha.in/us/stocks/npki) $765 million
7. [Janus International Group, Inc.](https://www.sectoralpha.in/us/stocks/jbi) $639 million

[All 27 Building Products & Equipment companies, largest first](https://www.sectoralpha.in/us/sectors/building-products-equipment#all-companies)

### Companies close in size in other industries

1. [Dream Finders Homes, Inc.](https://www.sectoralpha.in/us/stocks/dfh) $991 million · Residential Construction
2. [Whitestone REIT](https://www.sectoralpha.in/us/stocks/wsr) $988 million · REIT - Retail
3. Quanex Building Products Corporation $987 million
4. [Marten Transport, Ltd.](https://www.sectoralpha.in/us/stocks/mrtn) $982 million · Trucking
5. [Apogee Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/apog) $981 million · Building Products & Equipment

## What else do people ask about Quanex Building Products? ### What were Quanex Building Products's latest quarterly results? Quanex Building Products Corporation reported revenue of $502 M and net profit of $26.5 M for the Jul 2026 quarter. Earnings per share were $0.58. The operating margin was 9.3%, 2.7 percentage points higher than a year earlier (as of 3 November 2026). ### What is Quanex Building Products's market cap? Quanex Building Products Corporation's market capitalisation is $955 M at a stock price of $21.04. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Quanex Building Products performing? Quanex Building Products Corporation's latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 1 week running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Quanex Building Products's stock price go up? This page does not forecast Quanex Building Products Corporation's stock price. What it shows instead: the stock price is $21.04. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Is Quanex Building Products's profit real cash? Yes, over the last 3 years, 164% of Quanex Building Products Corporation's reported profit came in as cash from operations. The latest year was lower at -66%, so the trend is worth watching. In FY25, operating cash was $165 M against reported profit of −$251 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Quanex Building Products in its business cycle? Quanex Building Products Corporation's FY25 operating margin was 7.0%, against a 5-year range of 4.4% to 9.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 9.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Quanex Building Products story? The main question: the share price moved +48.1% in a year while yearly earnings per share moved −703.6%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Quanex Building Products a stock worth studying right now? What the numbers show: Quanex Building Products Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.